EuroEyes Announces Availability of 2026 Interim Report and Outlines Shareholder Communication Options

Bulletin Express
昨天

EuroEyes International Eye Clinic Limited released a shareholder notification dated 22 September 2026 confirming that its 2026 Interim Report is now accessible in both English and Chinese on the company’s website (ir.euroeyes.hk) and on the Hong Kong Stock Exchange’s HKEXnews platform (www.hkexnews.hk).

The board recommends stakeholders use the online version for immediate access. Non-registered shareholders who are unable to view or receive the electronic document may request a hard copy—free of charge—by completing and returning the enclosed request form to the Hong Kong branch share registrar, Tricor Investor Services Limited, via post (pre-paid label provided) or email (1846-ecom@vistra.com).

Investors holding shares through intermediaries (banks, brokers, custodians, nominees or HKSCC Nominees Limited) can opt to receive future corporate communications electronically by supplying their functional email address to those intermediaries. Until a valid email is on record, such investors will continue to receive printed notices of publication by post.

Queries can be directed to Tricor Investor Services Limited’s hotline on +852 2980 1333 during business hours (9:00 a.m.–6:00 p.m., Monday to Friday, excluding public holidays).

The notification was issued by Dr. Jørn Slot Jørgensen, Chairman and Executive Director of EuroEyes International Eye Clinic Limited, on behalf of the board.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10